Clinical Science Director
ViiV Healthcare, Brentford, UK, United Kingdom
Disclosure(s): GlaxoSmithKline: Stocks/Bonds; ViiV Healthcare: Employee
Mounir Ait-Khaled, PhD, serves as Clinical Science Director at ViiV Healthcare. Dr Ait-Khaled, a molecular biologist and clinical virologist by training at King’s College London and the Royal Free Hospital London, joined GlaxoSmithKline in 1997 and then moved to ViiV Healthcare in 2014. He has over 28 years of experience working in the field of HIV with special interest in HIV drug resistance and all phases clinical trials. Dr Ait-Khaled has held key positions on 5 different product development teams, where he contributed to protocols, clinical study reports, and regulatory submissions. He also has experience organizing advisory boards and leading external collaborations. Since 2008, he has been the clinical study leader for numerous clinical trials of an HIV integrase inhibitor development program. Dr Ait-Khaled has authored over 50 peer-reviewed articles and over 100 conference presentations, and has also served as a peer reviewer for medical journals.